<p>On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.</p>

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

<p>On this week’s Few &amp; Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds&nbsp;and how they can jumpstart funding in clinical research for rare disease and other disorders.</p>

Episode 18: Karen Petrou and David Brint - BioBonds

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

Welcome to Few &amp; Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Share Episode 18: Karen Petrou and David Brint - BioBonds

Sign up to save your podcasts

Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18: Karen Petrou and David Brint - BioBonds